| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |